DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience-Reference-Cited by-同舟云学术

DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience

Published:2017-11-04 Issue:3 Volume:34 Page:454-459
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

Ganesan Prasanth^ORCID,Ganesan Trivadi S.,Atreya Harshvardhan,Kannan Krishnarathinam,Radhakrishnan Venkatraman,Dhanushkodi Manikandan,Joshua Thanda Lucy Ann,Sundersingh Shirley,Sagar Tenali Gnana

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/s12288-017-0901-1/fulltext.html

Reference14 articles.

1. Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C et al (2013) Low-intensity therapy in adults with Burkitt’s lymphoma. N Engl J Med 369(20):1915–1925

2. Dunleavy K, Fanale M, LaCasce A, Noy A, Caimi P, Parekh S et al (2014) Preliminary report of a multicenter prospective phase II study of DA-EPOCH-R in MYC-rearranged aggressive B-cell lymphoma. Blood 2014(124):395

3. Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J et al (2013) Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med 368(15):1408–1416

4. Thomas DA, Faderl S, O’Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G et al (2006) Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 106(7):1569–1580

5. Evens AM, Carson KR, Kolesar J, Nabhan C, Helenowski I, Islam N et al (2013) A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt’s lymphoma. Ann Oncol 24(12):3076–3081

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Composite Burkitt Lymphoma and Classical Hodgkin Lymphoma in an Human Immunodeficiency Virus (HIV)-Positive Patient;Cureus;2024-06-21

2. Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4068 patients;Haematologica;2023-08-31

3. Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions;Frontiers in Oncology;2021-03-22

4. Consenso del Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL) para el manejo del Linfoma en estado de Pandemia SARS CoV-2 / COVID 19;Revista Colombiana de Cancerología;2020-11-30

5. Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol;Indian Journal of Hematology and Blood Transfusion;2020-06-05